Veda Rowe
Psychiatric/Mental Health · Marion, NCNPI 1720040314
Payments from drug & device makers
Across 183 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$322
- Alkermes, Inc.$320
- AbbVie$144
- Collegium Pharmaceutical, Inc.$118
- Johnson & Johnson$57
- plus $240 from 6 others
What the payments were for
- Food & beverage$3,37495%
- Education$1605%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$375
- Austedo XR$239
How this compares
$3,534 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 17 | $170,821 |
| Austedo XrDeutetrabenazine | 26 | $66,796 |
| Abilify MaintenaAripiprazole | 20 | $55,158 |
| Clozapine | 39 | $3,799 |
| Atomoxetine Hcl | 19 | $3,693 |
| Hydroxyzine Hcl | 98 | $2,790 |
| Haloperidol | 52 | $2,606 |
| Olanzapine | 75 | $2,066 |
| Quetiapine Fumarate | 56 | $1,603 |
| Lorazepam | 57 | $1,526 |
| Trazodone Hcl | 75 | $1,501 |
| Buspirone Hcl | 95 | $1,452 |
| Haloperidol Decanoate | 23 | $1,385 |
| Risperidone | 40 | $1,308 |
| Divalproex Sodium ErDivalproex Sodium | 25 | $1,225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza | $57 | $170,82117 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $2,333 | $66,79626 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $322 | $55,15820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Marion
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.